The use of vascular closure devices and impact on major bleeding and net adverse clinical events (NACEs) in balloon aortic valvuloplasty: A sub-analysis of the BRAVO study

Catheterization and Cardiovascular Interventions

Volumn 83, Issue 1, 2014, Pages 148-153

  O'Neill, Brian ^a   Singh, Vikas ^a   Kini, Annapoorna ^b   Mehran, Roxana ^b   Jacobs, Evan ^a   Knopf, David ^a   Alfonso, Carlos E ^a   Martinez, Claudia A ^a   Martinezclark, Pedro ^a   O'Neill, William ^a   Heldman, Alan W ^a   Yu, Jennifer ^b   Baber, Usman ^b   Kovacic, Jason C ^b   Dangas, George ^b   Sharma, Samin ^b   Sartori, Samantha ^b   Cohen, Mauricio G ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

aortic stenosis; balloon aortic valvuloplasty; bleeding; closure devices

Indexed keywords

HEPARIN; HIRULOG;

AORTIC VALVE REPAIR; ARTICLE; BALLOON AORTIC VALVULOPLASTY; BLEEDING; CARDIOVASCULAR SURGICAL EQUIPMENT; COMPRESSION THERAPY; CONTROLLED STUDY; DRUG USE; FEMALE; HEMOSTASIS; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PERIPHERAL VASCULAR DISEASE; RETROSPECTIVE STUDY; VASCULAR CLOSURE DEVICE; VASCULAR SUTURE; VERY ELDERLY;

AORTIC STENOSIS; BALLOON AORTIC VALVULOPLASTY; BLEEDING; CLOSURE DEVICES;

ACADEMIC MEDICAL CENTERS; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ANTITHROMBINS; AORTIC VALVE STENOSIS; BALLOON VALVULOPLASTY; CHI-SQUARE DISTRIBUTION; EQUIPMENT DESIGN; FEMALE; FEMORAL ARTERY; FLORIDA; HEMORRHAGE; HEMOSTATIC TECHNIQUES; HEPARIN; HIRUDINS; HOSPITALS, HIGH-VOLUME; HUMANS; LOGISTIC MODELS; MALE; MULTIVARIATE ANALYSIS; NEW YORK CITY; ODDS RATIO; PEPTIDE FRAGMENTS; PUNCTURES; RECOMBINANT PROTEINS; RETROSPECTIVE STUDIES; RISK FACTORS; SUTURE TECHNIQUES; TREATMENT OUTCOME;

EID: 84890561978     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.24892     Document Type: Article

References (28)

1. Mehta SK, Frutkin AD, Lindsey JB, et al. Bleeding in patients undergoing percutaneous coronary intervention: The development of a clinical risk algorithm from the National Cardiovascular Data Registry. Circ Cardiovasc Interv 2009; 2: 222-229.
2. Pedersen WR, Klaassen PJ, Boisjolie CR, et al. Feasibility of transcatheter intervention for severe aortic stenosis in patients >or=90 years of age: Aortic valvuloplasty revisited. Catheter Cardiovasc Interv 2007; 70: 149-154.
3. Yang X, Alexander KP, Chen AY, et al. The implications of blood transfusions for patients with non-ST-segment elevation acute coronary syndromes: Results from the CRUSADE National Quality Improvement Initiative. J Am Coll Cardiol 2005; 46: 1490-1495.
4. Veenith T, Sharples L, Gerrard C, Valchanov K, Vuylsteke A,. Survival and length of stay following blood transfusion in octogenarians following cardiac surgery. Anaesthesia 2010; 65: 331-336.
5. Rao SV, O'Grady K, Pieper KS, et al. A comparison of the clinical impact of bleeding measured by two different classifications among patients with acute coronary syndromes. J Am Coll Cardiol 2006; 47: 809-816.
6. Marso SP, Amin AP, House JA, et al. Association between use of bleeding avoidance strategies and risk of periprocedural bleeding among patients undergoing percutaneous coronary intervention. JAMA 2010; 303: 2156-2164.
7. Baim DS, Knopf WD, Hinohara T, et al. Suture-mediated closure of the femoral access site after cardiac catheterization: Results of the suture to ambulate aNd discharge (STAND I and STAND II) trials. Am J Cardiol 2000; 85: 864-869.
8. Dauerman HL, Applegate RJ, Cohen DJ,. Vascular closure devices: the second decade. J Am Coll Cardiol 2007; 50: 1617-1626.
9. Cockburn J, de Belder A, Brooks M, et al. Large calibre arterial access device closure for percutaneous aortic valve interventions: Use of the prostar system in 118 cases. Catheter Cardiovasc Interv 2012; 79: 143-149.
10. Dauerman HL, Rao SV, Resnic FS, Applegate RJ,. Bleeding avoidance strategies. Consensus and controversy. J Am Coll Cardiol 2011; 58: 1-10.
11. Patel MR, Jneid H, Derdeyn CP, et al. Arteriotomy closure devices for cardiovascular procedures: A scientific statement from the American Heart Association. Circulation 2010; 122: 1882-1893.
12. Mehran R, Rao SV, Bhatt DL, et al. Standardized bleeding definitions for cardiovascular clinical trials: A consensus report from the Bleeding Academic Research Consortium. Circulation 2011; 123: 2736-2747.
13. Chesebro JH, Knatterud G, Roberts R, et al. Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge. Circulation 1987; 76: 142-154.
14. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. The GUSTO investigators. N Engl J Med 1993; 329: 673-682.
15. Leon MB, Piazza N, Nikolsky E, et al. Standardized endpoint definitions for Transcatheter Aortic Valve Implantation clinical trials: A consensus report from the Valve Academic Research Consortium. J Am Coll Cardiol 2011; 57: 253-269.
16. Lee WA, Brown MP, Nelson PR, Huber TS,. Total percutaneous access for endovascular aortic aneurysm repair («Preclose» technique). J Vasc Surg 2007; 45: 1095-1101.
17. Percutaneous balloon aortic valvuloplasty. Acute and 30-day follow-up results in 674 patients from the NHLBI Balloon Valvuloplasty Registry. Circulation 1991; 84: 2383-2397.
18. Ben-Dor I, Looser P, Bernardo N, et al. Comparison of closure strategies after balloon aortic valvuloplasty: Suture mediated versus collagen based versus manual. Catheter Cardiovasc Interv 2011; 78: 119-124.
19. Ndrepepa G, Schuster T, Hadamitzky M, et al. Validation of the Bleeding Academic Research Consortium definition of bleeding in patients with coronary artery disease undergoing percutaneous coronary intervention. Circulation 2012; 125: 1424-1431.
20. Dangas G, Mehran R, Kokolis S, et al. Vascular complications after percutaneous coronary interventions following hemostasis with manual compression versus arteriotomy closure devices. J Am Coll Cardiol 2001; 38: 638-641.
21. Allen DS, Marso SP, Lindsey JB, Kennedy KF, Safley DM,. Comparison of bleeding complications using arterial closure device versus manual compression by propensity matching in patients undergoing percutaneous coronary intervention. Am J Cardiol 2011; 107: 1619-1623.
22. Lincoff AM, Bittl JA, Harrington RA, et al. Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial. JAMA 2003; 289: 853-863.
23. Stone GW, McLaurin BT, Cox DA, et al. Bivalirudin for patients with acute coronary syndromes. N Engl J Med 2006; 355: 2203-2216.
24. Stone GW, Witzenbichler B, Guagliumi G, et al. Bivalirudin during primary PCI in acute myocardial infarction. N Engl J Med 2008; 358: 2218-2230.
25. Kaul S, Diamond GA,. Trial and error. How to avoid commonly encountered limitations of published clinical trials. J Am Coll Cardiol 2010; 55: 415-427.
26. McKay RG,. The Mansfield Scientific Aortic Valvuloplasty Registry: Overview of acute hemodynamic results and procedural complications. J Am Coll Cardiol 1991; 17: 485-491.
27. Ben-Dor I, Pichard AD, Satler LF, et al. Complications and outcome of balloon aortic valvuloplasty in high-risk or inoperable patients. JACC Cardiovasc Interv 2010; 3: 1150-1156.
28. Starnes BW, O'Donnell SD, Gillespie DL, et al. Percutaneous arterial closure in peripheral vascular disease: A prospective randomized evaluation of the Perclose device. J Vasc Surg 2003; 38: 263-271.